miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer

Villéger, 2018, Microbial markers in colorectal cancer detection and/or prognosis, World J. Gastroenterol., 24, 2327, 10.3748/wjg.v24.i22.2327 Siegel, 2017, Colorectal cancer statistics, 2017, CA Cancer J. Clin, 67, 177, 10.3322/caac.21395 Farazi, 2013, MicroRNAs in human cancer, Adv. Exp. Med. Biol., 774, 1, 10.1007/978-94-007-5590-1_1 Bandrés, 2006, Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues, Mol. Cancer, 5, 29, 10.1186/1476-4598-5-29 Liang, 2013, miR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer, Carcinogenesis, 34, 713, 10.1093/carcin/bgs383 Yang, 2017, Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer, Oncol. Lett., 14, 3429, 10.3892/ol.2017.6607 Wang, 2016, miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL, BMC Cancer, 16, 826, 10.1186/s12885-016-2862-4 Hu, 2017, miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4, OncoTargets Ther., 10, 2711, 10.2147/OTT.S135563 Cai, 2016, miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4, Oncol. Rep., 35, 284, 10.3892/or.2015.4355 Yang, 2017, miR-124 inhibits proliferation, migration and invasion of malignant melanoma cells via targeting versican, Exp. Ther. Med., 14, 3555, 10.3892/etm.2017.4998 Tian, 2017, miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis, BMC Cancer, 17, 175, 10.1186/s12885-017-3166-z Qiao, 2017, miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA, Biochem. Biophys. Res. Commun., 486, 43, 10.1016/j.bbrc.2017.02.120 Wang, 2016, Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis, Sci. Rep., 6, 36796, 10.1038/srep36796 Wang, 2013, Downregulation of microRNA-124 is an independent prognostic factor in patients with colorectal cancer, Int. J. Colorectal Dis., 28, 183, 10.1007/s00384-012-1550-3 Wyatt, 2009, Participation of DNA repair in the response to 5-fluorouracil, Cell. Mol. Life Sci., 66, 788, 10.1007/s00018-008-8557-5 Ahmad, 2010, Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes, Chem. Biodivers., 7, 543, 10.1002/cbdv.200800340 Marschner, 2015, Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer—results from a prospective cohort study, Clin. Epidemiol, 7, 295, 10.2147/CLEP.S73857 Goll, 2003, The calpain system, Physiol. Rev., 83, 731, 10.1152/physrev.00029.2002 Lakshmikuttyamma, 2004, Overexpression of m-calpain in human colorectal adenocarcinomas, Cancer Epidemiol. Biomarkers Prev., 13, 1604, 10.1158/1055-9965.1604.13.10 Rose, 2015, Calpain-2 inhibitor therapy reduces murine colitis and colitis-associated cancer, Inflamm. Bowel Dis., 21, 2005, 10.1097/MIB.0000000000000471 Storr, 2012, Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer, J. Cell. Mol. Med., 16, 2422, 10.1111/j.1582-4934.2012.01559.x Hayward, 2004, Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect, Mol. Cancer Ther., 3, 169, 10.1158/1535-7163.169.3.2 Liu, 2017, Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line, Cell Death Dis., 8, e3096, 10.1038/cddis.2017.477 Salehin, 2011, Immunhistochemical analysis for expression of calpain 1, calpain 2 and calpastatin in ovarian cancer, Eur. J. Gynaecol. Oncol., 32, 628